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Abstract
The total synthesis of decarboxyaltenusin (5’-methoxy-6-methyl-[1,1’-biphenyl]-3,3’,4-triol), a toxin produced by various mold
fungi, has been achieved in seven steps in a yield of 31% starting from 4-methylcatechol and 1-bromo-3,5-dimethoxybenzene,
where the longest linear sequence consists of five steps. The key reaction was a palladium-catalyzed Suzuki coupling of an aromat-
ic boronate with a brominated resorcin derivative.
Introduction
5’-Methoxy-6-methyl-[1,1’-biphenyl]-3,3’,4-triol (1, Scheme 1)
has been first mentioned 1974 as a reduction and decarboxyl-
ation product of dehydroaltenusin [1]. As the compound has
later been isolated from Ulocladium sp. [2], Nigrospora
sphaerica, Phialophora sp. [3], Penicillium pinophilum SD-272
[4], Alternaria sp. [3,5,6], and from the endophytic fungus
Botryosphaeria dothidea in Melia azedarach [7] it turned out to
be a widely occurring natural product. It shows marked DPPH
radical scavenging activities with determined IC50 values of
18.7 ± 0.2 μM [7] and 148 ± 3 μM [2], respectively, and
displays inhibitory activity against three tyrosine kinases
(EGFR, VEGFR-1, and c-Met) [5]. As mentioned, it is acces-
sible through the reduction of dehydroaltenusin with zinc
powder in acetic acid with intermediate formation of altenusin
[1]. Nevertheless, this route cannot be considered as a viable ap-
proach to this compound due to the reduced accessibility of the
precursors and since no experimental details have been
published for the transformation. To continue our efforts in the
total synthesis of mycotoxins [8-18] and to provide larger
amounts of the polyketide 1 sufficient for thorough biological
investigations (as have been suggested by the European Food
Safety Authority, EFSA [19]), we considered it useful to supply
a more straightforward synthesis of this compound, for which
we here propose the obvious name decarboxyaltenusin.
Results and Discussion
In a retrosynthetic analysis, we envisioned a Suzuki coupling of
two suitably substituted arenes. Silyl protecting groups like the
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Scheme 2: Synthesis of arylboronates 6. Conditions: a) TBSCl, DMAP, imidazole, DMF, 50 °C, 4 h (96%); b) NBS, MeCN, rt, 71 h (quant.); c) NBS,
MeCN, rt, 72 h (R = TBS, 96%); d) BnBr, KI, K2CO3, DMF/acetone, 70 °C, 29 h, (R = Bn, 86%); e) R = TBS: BuLi, 2-isopropoxy-4,4,5,5-tetramethyl-
1,3,2-dioxaborolane, THF, −78 °C, 0.45–2 h, rt, 18 h (57%); R = Bn: bis(pinacolato)diboron, Pd(dppf)Cl2·CH2Cl2 (cat.), KOAc, dioxane, 80 °C, 17 h
(55%).
Scheme 1: Biphenyl-derived mycotoxins.
tert-butyldimethylsilyl group (TBS) were considered appro-
priate for all projected reaction steps. The boronate moiety 6a
was prepared starting with 4-methylcatechol (2), which was
initially protected with tert-butyldimethylsilyl chloride in the
presence of 4-(dimethylamino)pyridine (DMAP) and imidazole
(Scheme 2) according to a published procedure [20]. The thus
obtained bis(silylether) 3 was then brominated with N-bromo-
succinimide (NBS), where the utilization of acetonitrile as sol-
vent [21] instead of carbon tetrachloride [22] furnished a close
to quantitative yield of bromide 5a, though a prolonged reac-
tion time of 72 h had to be accepted. The subsequent formation
of boronate 6a was accomplished through a metal–halogen
interchange with butyllithium and trapping with 2-isopropoxy-
4,4,5,5-tetramethyl-1,3,2-dioxaborolane [23].
The electrophilic compound suitable for the projected cross
coupling was obtained by mono-demethylation of commercial-
ly available 1-bromo-3,5-dimethoxybenzene (7) with boron
tribromide (Scheme 3). A satisfactory yield of phenol 8 was ob-
served with 0.9 equivalents of the Lewis acid, while the utiliza-
tion of 1.5 equivalents led to a significant overreaction with the
predominant formation of 5-bromobenzene-1,3-diol (59%)
together with a smaller amount of the required product 8 (30%).
The subsequent protection with the TBS group yielded the
known aryl bromide 9a [24] with a 73% yield.
Scheme 3: Synthesis of aryl bromides 9. Conditions: f) BBr3, −78 °C
to rt, 18 h (71%); g) R = TBS: TBSCl, DMAP, imidazole, DMF, 55 °C,
4 h (73%); R = Bn: BnBr, K2CO3, DMF/acetone 1:2, 80 °C, 43 h
(98%).
The Suzuki coupling of boronate 6a and aryl bromide 9a using
palladium acetate and cesium carbonate in the presence of the
ligand SPhos [25] yielded biaryl 10a with virtually quantitative
yield (98%, Scheme 4). Unfortunately, the removal of non-
identified byproducts and of 9a (which had been used in a
1.2-fold excess) turned out to be very laborious. Moreover,
the subsequent deprotection to the natural product 1
could not be achieved sufficiently: After treatment of 10a
with tetrabutylammonium fluoride (TBAF), the signals of 1
could be detected in a 1H NMR spectrum of the crude product,
but purification and isolation of the product by column chroma-
tography was not possible ‒ neither with conventional nor with
reversed phase methods. It turned out that the high polarity of
the triol complicated its separation from other polar side prod-
ucts.
To circumvent this problem, we decided to use a different
protection group strategy and to employ hydrogenolytically
cleavable benzyl groups. The synthesis of the benzyl-protected
boronate was here achieved with a modified strategy including
bromination [21] of 4-methylcatechol (2) to the known bro-
mide 4 [26] and subsequent benzyl protection to the bis(benzyl
ether) 5b using standard conditions (Scheme 2) [27]. The prepa-
ration of boronate 6b applying the conditions used for the sily-
lated substrate 6a (vide supra) led to a mediocre 44% yield, but
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Scheme 4: Final steps in the synthesis of biaryl 1. Conditions: h) Pd(OAc)2, SPhos, Cs2CO3, dioxane/H2O 7:1, 70 °C, 18 h, (R = TBS: 98%, contain-
ing non-separable impurities; R = Bn: 89%) ; i) R = Bn: Pd/C (10%), H2, THF, 8 bar, 24 h, 40 °C (88%).
Table 1: NMR data of natural and synthetic biaryl 1.
natural product synthetic product deviationa
δ [ppm]b,c δ [ppm]c,d signal δ [ppm] Δδ [ppm]
19.8 19.50 6-Me 19.4 −0.4/−0.1
55.4 54.97 OMe 54.9 −0.5/−0.1
99.7 99.21 C-4’ 99.2 −0.5/±0.0
106.2 105.80 C-2’ 105.8 −0.4/±0.0
109.3 108.84 C-6’ 108.8 −0.5/±0.0
117.1 116.70 C-2 116.7 −0.4/±0.0
118.0 117.56 C-5 117.5 −0.5/−0.1
125.3 124.89 C-6 124.8 −0.5/−0.1
132.7 132.30 C-1 132.3 −0.4/±0.0
143.5e,f 142.92 C-1’ 142.9 −0.6/±0.0
144.5e,f 143.66 C-3 143.6 −0.9/−0.1
144.8e,f 144.39 C-4 144.3 −0.5/−0.1
158.5 158.06 C-3’ 158.0 −0.5/−0.1
160.4 160.04 C-5’ 160.0 −0.4/±0.0
2.05 (s) 6-CH3 2.05 (s) ±0.00
3.69 (s) 5’-OCH3 3.70 (s) +0.01
6.20 (br. s) 6’-H 6.20 (dd) ±0.00
6.21 (br. s) 2’-H 6.22 (t) +0.01
6.25 (br. s) 4’-H 6.25 (t) ±0.00
6.54 (s) 2-H 6.55 (s) +0.01
6.60 (s) 5-H 6.60 (s) ±0.00
8.72 (br. s) 3-OH 8.72 (br. s) ±0.00
8.78 (br. s) 4-OH 8.78 (br. s) ±0.00
9.42 (br. s) 3’-OH 9.37 (br. s) − 0.05
aDeviation of the synthesized product’s data from published data: Wang et al. [2]/Xiao et al. [7]; bdata published by Wang et al. [2]; cthe data are given
in ascending order. Assignments in the original papers are in agreement with those given for the synthesized product (except footnote e); ddata
published by Xiao et al. [7]; ethe assignment in the original paper is: 143.5: C-4, 144.5: C-3, and 144.8: C-1’; fa superscript letter is included after
these numbers in the original paper, but a corresponding footnote is missing. It can be assumed that the assignment of these signals had been
considered questionable.
the utilization of a palladium-catalyzed borylation with
bis(pinacolato)diboron afforded the product with 55% yield.
The O-benzylation of phenol 8 furnishing the bromide 9b was
accomplished with virtually quantitative yield. Suzuki coupling
of the benzyl-protected compounds 6b and 9b led to biaryl 10b
with 89% yield; it was deprotected with palladium on charcoal
under eight bar hydrogen pressure (Scheme 4). The product 1
could now be purified by a simple chromatography on silica gel
and was obtained in 88% yield.
NMR spectroscopic data of the natural product had been
published by Wang et al. [2] and by Xiao et al. [7] (Table 1). A
comparison of the 13C NMR data of the now synthesized com-
pound with Wang’s data shows a systematic deviation of about
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−0.5 ppm (possibly due to a calibration inaccuracy in the orig-
inal paper) and a deviant signal around 144 ppm, which is a
further −0.4 ppm off (marked in boldface). Nevertheless, all
signals published by Xiao et al. are in virtually perfect agree-
ment with the NMR data measured by us, what leaves no rea-
sonable doubt that the synthesized structure 1 is identical with
the natural product.
Decarboxyaltenusin (1) was screened for toxicity towards
human HeLa cells but proved nontoxic at biologically relevant
concentrations and showed an LD50 value of above 50 μM. This
screening was performed by measuring the cell viability using
an MTT assay, where the viability is assessed based upon the
reduction of the yellow tetrazolium MTT [3-(4,5-dimethylthia-
zolyl-2)-2,5-diphenyltetrazolium bromide] by metabolically
active and hence viable cells. The resulting intracellular purple
formazan was quantified spectrophotometrically. The cell
viability was calculated based on an untreated control. The
cell viability cut-off was <70%. At a 0.5 μM concentration of
decarboxyaltenusin (1), it was 103% ± 1%, at 5 μM it was
94% ± 1.4%, and at 50 μM 92% ± 1%.
Conclusion
The total synthesis of decarboxyaltenusin (1) was achieved in
seven steps in a yield of 31% starting from 4-methylcatechol (2)
and 1-bromo-3,5-dimethoxybenzene (7), where the longest
linear sequence has consisted of five steps. Decarboxyaltenusin
turned out to be nontoxic towards human HeLa cells.
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